Mepolizumab reduces moderate to severe COPD exacerbations in patients with varying blood eosinophil counts and type 2 inflammation.

Abbott (NYSE: ABT) today the FDA approved its CardioMEMS Hero next-generation pulmonary artery (PA) pressure reader.

Sepsis-associated encephalopathy affects about two-thirds of patients with sepsis and pulmonary infection and is linked to higher mortality.

Liquidia has rapidly captured 16% market share in pulmonary hypertension since launching Yutrepia in June 2025. Click to read my latest analysis of LQDA stock.

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...

Malaysia has a new national plan to tackle cancer, tuberculosis, and chronic respiratory conditions in a single approach. Jacqui Thornton reports.

Memorial Hospital and Manor held a ribbon cutting with the Bainbridge-Decatur County Chamber of Commerce Tuesday to celebrate ...

Findings based on comparison to glycopyrrolate-formoterol and tiotropium-olodaterol in patients newly prescribed LAMA-LABA inhalers.

Cold weather places additional stress on the heart, leading to an increased risk of cardiac events during northern Michigan winters. Structured support programs, such as the Better Breathing program, ...

Use of race-based reference equations in pulmonary function testing has led to thresholds for what qualifies as impairment in populations.

According to a Center for Healthcare Quality and Payment Reform report, 756 hospitals in the rural United States are at risk ...

Proton pump inhibitor (PPI) use in patients with chronic obstructive airway diseases is associated with an increased exacerbation risk.